Dianthus Therapeutics annual operating margin
2023
2024
2025
Dianthus Therapeutics Operating Margin Growth & History (DNTH)
Dianthus Therapeutics's operating margin was −8,739.34% for fiscal 2025.
View full Dianthus Therapeutics company overviewDianthus Therapeutics annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −8,739.34% | −7105.60 pp |
| 2024 | 2024-12-31 | −1,633.74% | +70.93 pp |
| 2023 | 2023-12-31 | −1,704.67% | — |
Dianthus Therapeutics quarterly operating margin
Q3.22
Q3.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q4 2025 | 2025-12-31 | −24,486.27% | −22079.33 pp |
| Q3 2025 | 2025-09-30 | −10,173.74% | −8797.13 pp |
| Q2 2025 | 2025-06-30 | −18,096.89% | −16905.05 pp |
| Q1 2025 | 2025-03-31 | −2,852.71% | −811.06 pp |
| Q4 2024 | 2024-12-31 | −2,406.94% | −701.42 pp |
| Q3 2024 | 2024-09-30 | −1,376.61% | −672.95 pp |
| Q2 2024 | 2024-06-30 | −1,191.84% | — |
| Q1 2024 | 2024-03-31 | −2,041.65% | — |
| Q3 2023 | 2023-09-30 | −1,705.52% | — |
| Q3 2022 | 2022-09-30 | −703.67% | — |
Dianthus Therapeutics operating margin trends
Across the available reported history, Dianthus Therapeutics's operating margin decreased from −1,633.74% to −8,739.34%, a change of −7105.60 percentage points. The latest reported quarter, Q4 2025, shows −24,486.27%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Dianthus Therapeutics filings at SEC.gov ↗